1. Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo
   Jianbao Zheng et al, 2017, International Journal of Oncology CrossRef
2. Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma
   Fabio Albuquerque Marchi et al, 2017, Scientific Reports CrossRef
3. Key Signaling Pathways Engaged in Cancer Management: Current Update
   Sanjiv Singh et al, 2020, Current Cancer Therapy Reviews CrossRef
4. Tumor vessel co-option: The past & the future
   Anne Cuypers et al, 2022, Frontiers in Oncology CrossRef
5. Association of Polymorphism in Survivin Gene and the Risk of Liver Cancer Resulting from Hepatitis C Virus Among Egyptian Patients
   Amal A. Mohamed et al, 2021, Current Cancer Drug Targets CrossRef
6. Combination of ARE and HRE cis-Regulatory Elements Elevates the Activity of Tumor-Specific hTERT Promoter
   S. V. Kalinichenko et al, 2021, Molecular Biology CrossRef
7. Xenobiotic Response Elements (XREs) from Human CYP1A1 Gene Enhance the hTERT Promoter Activity
   M. V. Shepelev et al, 2019, Doklady Biochemistry and Biophysics CrossRef
8. Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors
   Abdul Mohin Sajib et al, 2020, PLOS ONE CrossRef
9. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt
   Tarek M.K. Motawi et al, 2019, Clinical Breast Cancer CrossRef
10. Construction of an Anoikis-Related Gene Prognostic Signature and Identification of ANGPTL4 as a Key Oncogene in Lung Adenocarcinoma
    Hao Lou et al, 2024, Molecular Biotechnology CrossRef